PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31068791-17	2019	Hence, a dynamic balance of P2Y1 and P2X7 receptors expression and function during AIS assembly and maturation may represent a fine regulatory mechanism in response to physiological or pathological extracellular purines concentration.	Purines	212-219	purinergic receptor P2Y1	Homo sapiens	28-32	
19781676-8	2010	In conclusion, LIPUS treatment induces osteoblastogenesis via the release of purines, such as ATP, activating P2Y receptors, mainly the P2Y(1) receptor.	Purines	77-84	purinergic receptor P2Y1	Homo sapiens	136-151	
16967306-1	2006	Purines are extracellular nucleotides that have long-term effects on keratinocyte proliferation, differentiation and death through P2Y(1), P2Y(2), P2X(5) and P2X(7) receptors.	Purines	0-7	purinergic receptor P2Y1	Homo sapiens	131-137	
28066160-8	2016	The "purinergic hypothesis" is that MS releases purines to act in an autocrine/paracrine manner to activate excitatory (P2Y1, P2Y4, P2Y6, and A2A/A2B) or inhibitory (P2Y12, A1, and A3) receptors to regulate 5-HT release.	Purines	48-55	purinergic receptor P2Y1	Homo sapiens	120-124	
17626796-11	2007	This up-regulation reflects a feedback circuit, mediated at least in part by the P2Y1 receptor, to regulate levels of extracellular purines in subretinal space.	Purines	132-139	purinergic receptor P2Y1	Homo sapiens	81-94